Literature DB >> 3409570

Treatment of chondromalacia patellae by lateral retinacular release of the patella.

F Christensen1, K Søballe, L Snerum.   

Abstract

A series of 59 knees in 58 patients were surgically treated from 1977 to 1982 for chondromalacia patellae, and were followed for an average of 1.2 to 4.6 years after the operation. The operative procedure was open lateral retinacular release in all knees. In knees with recurrent patellar subluxation, the number of poor results increased from 24% to 70%, and in knees with no subluxation from 21% to 24%. The difference after 4.6 years was statistically significant. No correlation between the severity or location of the cartilage changes and the operative effect was found. Open lateral retinacular release is an acceptable treatment of chondromalacia patellae without subluxation of the patella, whereas in the presence of recurrent subluxation, the release does not correct the basic biomechanical disturbance.

Entities:  

Mesh:

Year:  1988        PMID: 3409570

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

Review 1.  [Lateral retinacular release].

Authors:  P Verdonk; F Bonte; R Verdonk
Journal:  Orthopade       Date:  2008-09       Impact factor: 1.087

2.  Adolescent patellofemoral pain: implicating the medial patellofemoral ligament as the main pain generator.

Authors:  Scott J Luhmann; Perry L Schoenecker; Matthew B Dobbs; J Eric Gordon
Journal:  J Child Orthop       Date:  2008-06-11       Impact factor: 1.548

Review 3.  Lateral patellar retinacular release: changes over the last ten years.

Authors:  Leonardo Pini Rosalem Marciano da Fonseca; Ednei Haruo Kawatake; Alberto de Castro Pochini
Journal:  Rev Bras Ortop       Date:  2017-06-15

4.  Open versus arthroscopic release for lateral patellar compression syndrome: a randomized-controlled trial.

Authors:  Sherwan A Hamawandi; Hazhar I Amin; Ameer Kadhim Al-Humairi
Journal:  Arch Orthop Trauma Surg       Date:  2021-04-07       Impact factor: 2.928

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.